Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hypertension and coronary heart disease

Abstract

The association of hypertension and coronary heart disease is a frequent one. There are several pathophysiologic mechanisms which link both diseases. Hypertension induces endothelial dysfunction, exacerbates the atherosclerotic process and it contributes to make the atherosclerotic plaque more unstable. Left ventricular hypertrophy, which is the usual complication of hypertension, promotes a decrease of ‘coronary reserve’ and increases myocardial oxygen demand, both mechanisms contributing to myocardial ischaemia. From a clinical point of view hypertensive patients should have a complete evaluation of risk factors for atherosclerosis, damage of arterial territories other than the coronary one, and of the extension and severity of coronary artery involvement. It is important to emphasise that complications and mortality of patients suffering a myocardial infarction are greater in hypertensive patients. Treatment should be aimed to achieve optimal values of blood pressure, and all the strategies to treat coronary heart disease should be considered on an individual basis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Assmann G, Schulte H . The Prospective Cardio-vascular Munster (PROCAM) study: prevalence of hyperlipidemia inpatients with hypertension and/or diabetes mellitus and the relationship to coronary heart disease Am Heart J 1988 116: 1713–1724

    Article  CAS  Google Scholar 

  2. Scandivanian Simvastatin Survival Study group. Randomized trial of cholesterol lowering in 4444patients with coronary artery disease: the Scandinavian Simvastatin Survival Study (4 S) Lancet 1994 344: 11383–1389

  3. Sacks FM et al. The effect of pravastatin on coronary events after myocardial infarction inpatients with average cholesterol levels: the cholesterol and recurrent events (CARE) trial N Engl J Med 1996 335: 1001–1009

    Article  CAS  Google Scholar 

  4. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin inpatients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 1998 339: 1349–1357

  5. Stamler J, Stamler R, Neaton JD . Blood pressure, systolic and diastolic, and cardiovascular risks. US population data Arch Int Med 1993 153: 598–615

    Article  CAS  Google Scholar 

  6. MacMahon S et al. Blood pressure,stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 1990 335: 765–774

    Article  CAS  Google Scholar 

  7. O'Donell CJ et al. Hypertension and borderlineisolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians Circulation 1997 95: 1132–1137

    Article  Google Scholar 

  8. Chobanian AV, Alexander RW . Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications Arch Int Med 1996 156: 1952–1956

    Article  CAS  Google Scholar 

  9. DeFronzo RA, Ferrannini E . Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease Diabetes Care 1991 14: 173–194

    Article  CAS  Google Scholar 

  10. Strauer BE . The concept of coronary flow reserve J Cardiovasc Pharmacol 1992 19 (Suppl 5): 67–80

    Article  Google Scholar 

  11. Chilian WM et al. Thyroxine-induced left ventricular hypertrophy in the rat: anatomical and physiological evidence for angiogenesis Cir Res 1985 57: 591–598

    Article  CAS  Google Scholar 

  12. Tomanek RJ et al. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy Circ Res 1986 58: 38–46

    Article  CAS  Google Scholar 

  13. Hamasaki S et al. Attenuated coronary flow reserve and vascular remodelling inpatients with hypertension and left ventricular hypertrophy J Am Coll Cardiol 2000 35: 1654–1660

    Article  CAS  Google Scholar 

  14. Strauer BE . Coronary hemodynamics in hypertensive heart disease. Basic concepts, clinical consequences, and experimental analysis of regression of hypertyensive microangiopathy Am J Med 1988 84 (Suppl 3A): 45–54

    Article  Google Scholar 

  15. Ito N et al. Remodelling of microvessels by coronary hypertension or cardiac hypertrophy J Mol Cell Cardiol 1994 26: 49–59

    Article  CAS  Google Scholar 

  16. Isoyama S . Myocardial hypertrophy and coronary circulation before and after relief of pressure overload. In: Maruyama Y, Janicki JS (eds) Cardiovascular Remodelling and Functional Interaction Springer-Verlag: Tokyo, Japan 1996 33–46

    Google Scholar 

  17. Isoyama S, Ito N, Satoh K, Takishima T . Collagen deposition and the reversal of coronary reserve in cardiac hypertrophy Hypertension 1992 20: 491–500

    Article  CAS  Google Scholar 

  18. Schawrzkopff B et al. Structural and functional alterations of the intramyocardial coronary arterioles inpatients with arterial hypertension Circulation 1993 88: 993–1003

    Article  Google Scholar 

  19. Tanaka M et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts and hearts with hypertensive cardiomyopathy Circulation 1987 75: 1130–1139

    Article  CAS  Google Scholar 

  20. Ito N, Isoyama S, Tokahashi T, Yakishima T . Coronary dilator reserve and morphological changes after relief of pressure overload rats J Mol Cell Cardiol 1993 25: 3–14

    Article  CAS  Google Scholar 

  21. Nitenberg A, Antony I . Epicardial coronary arteries are not adequately sized in hypertensivepatients J Am Coll Cardiol 1996 27: 115–123

    Article  CAS  Google Scholar 

  22. Kannel WB, Cobb J . Left ventricular hypertrophy and mortality: results from the Framingham Study Cardiology 1992 81: 291–298

    Article  CAS  Google Scholar 

  23. MacMahon S, Rodgers A . The effects of blood pressure reduction in olderpatients: an overview of five randomized controlled trials in elderly hypertensives Clin Exp Hypertens 1993 15: 967–978

    Article  CAS  Google Scholar 

  24. Patsy BM et al. Health outcomes associated with antihypertensive therapies used as first line agents: a systematic review and metaanylisis JAMA 1997 277: 739–745

    Article  Google Scholar 

  25. Hamsson L et al. Effects of intensive blood pressure lowering and low dose aspirin inpatients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group Lancet 1998 351: 1755–1762

    Article  Google Scholar 

  26. Sullivan JM, Francis ChK . Management of hypertensivespatients with ischemic heart disease. In: Izzo JL, Black HR (eds) Hypertension Primer, 2nd edn Lippincott Williams and Wilkins: Maryland 1999 398–401

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Escobar, E. Hypertension and coronary heart disease. J Hum Hypertens 16 (Suppl 1), S61–S63 (2002). https://doi.org/10.1038/sj.jhh.1001345

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001345

Keywords

This article is cited by

Search

Quick links